Phase I trial of RDEA 3170 in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 07 Nov 2011
At a glance
- Drugs Verinurad (Primary)
- Indications Gout
- Focus Adverse reactions
- 07 Nov 2011 Results presented at the 75th Annual Scientific Meeting of the American College of Rheumatology and the 46th Annual Meeting of the Association of Rheumatology Health Professionals, according to an Ardea Biosciences media release.
- 07 Nov 2011 Status changed from not yet recruiting to recruiting.
- 09 Aug 2011 New trial record